Exclusion of ‘nonRCT evidence’ in guidelines for chronic diseases – is it always appropriate? The Look AHEAD study

References

• Guyatt G, Cook D, Haynes B. Evidence based medicine has come a long way. BMJ 2004;329:990-1
   PubMed Web of Science ®Google Scholar
• Dawes M, Summerskill W, Glasziou P, et al. Sicily statement on evidence-based practice. BMC Med Educ 2005;5:1
   PubMedGoogle Scholar
• Sanson-Fisher RW, Bonevski B, Green LW, et al. Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med 2007;33:155-61
   PubMed Web of Science ®Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-8
   PubMed Web of Science ®Google Scholar
• Roseman M, Milette K, Bero LA, et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011;305:1008-17
   Google Scholar
• Feuerstein JD, Akbari M, Gifford AE, et al. Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines. Mayo Clin Proc 2014;89:16-24
   PubMed Web of Science ®Google Scholar
• Bouri S, Shun-Shin MJ, Cole GD, et al. Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart Mar 2013;100:456-64
   PubMed Web of Science ®Google Scholar
• Luscher TF, Gersh B, Landmesser U, et al. Is the panic about beta-blockers in perioperative care justified? Eur Heart J 2014 Feb 6. Epub ahead of print. Doi:10.1093/eurheartj/ehu056
   Google Scholar
• Mente A, de Koning L, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009;169:659-69
   PubMed Web of Science ®Google Scholar
• Hammerstrom KT, Bjorndal A. If there are no randomised controlled trials, do we always need more research? Cochrane Database Syst Rev 2011;8:ED000024
   PubMedGoogle Scholar
• Higgins JPT. Cochrane Handbook for Systematic Reviews of Interventions Version. The Cochrane Collaboration. 2011. Available at: http://www.cochrane-handbook.org [Last accessed 8 May 2014]
   Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. Rating the quality of evidence and strength of recommendations: what is ‘quality of evidence’ and why is it important to clinicians? BMJ 2008;336:995-8
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press, 2011. Available at: http://www.nap.edu/catalog.php?record id=13058 [Last accessed 8 May 2014]
   Google Scholar
• Kavanagh BP. The GRADE System for Rating Clinical Guidelines. PLoS Med 2009;6:e1000094
   PubMed Web of Science ®Google Scholar
• Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004;170:477-80
   PubMed Web of Science ®Google Scholar
• Bes-Rastrollo M, Schulze MB, Ruiz-Canela M, et al. Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: a systematic review of systematic reviews. PLoS Med 2013;578:e78
   Google Scholar
• Ross JS, Tse T, Zarin DA, et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2013;344:d7292
   Google Scholar
• Krumholz HM. Missing data. The elephant that's not in the room. NEJM Practice Community 2012. Available at: http://www.cardioexchange.org/voices/missing-data-the-elephant-that’s-not-in-the-room [Last accessed 23 April 2014]
   Google Scholar
• Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124
   PubMed Web of Science ®Google Scholar
• Bossuyt PM. The thin line between hope and hype in biomarker research. JAMA 2011;305:2229-30
   PubMed Web of Science ®Google Scholar
• Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false – but a little replication goes a long way. PLoS Med 2007;4:e28
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Panagiotou OA. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA 2011;305:2200-10
   PubMed Web of Science ®Google Scholar
• Berenson GS. Bogalusa Heart Study: a long-term community study of a rural biracial (black/white) population. Am J Med Sci 2001;322:267-74
   PubMed Web of Science ®Google Scholar
• Van Horn LV, Ballew C, Liu K, et al. Diet, body size, and plasma lipids – lipoproteins in young adults: differences by race and sex. The Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol 1991;133:9-23
   PubMed Web of Science ®Google Scholar
• Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992;268:2420-5
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-30
   PubMed Web of Science ®Google Scholar
• Braithwaite RS. A piece of my mind. EBM's six dangerous words. JAMA 2013;310:2149-50
   PubMedGoogle Scholar
• Demicheli V, Jefferson T, Rivetti A, et al. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2005;4:CD004407
   PubMedGoogle Scholar
• Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomized controlled trials. BMJ 2003;327:1459-61
   PubMed Web of Science ®Google Scholar
• Lehman R, Loder E. Missing clinical trial data. BMJ 2012;344:d8158
   PubMed Web of Science ®Google Scholar
• Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA 2012;307:1583-4
   PubMed Web of Science ®Google Scholar
• Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA 2013;310:2503-4
   PubMed Web of Science ®Google Scholar
• Kent DM, Shah ND. Risk models and patient-centered evidence: should physicians expect one right answer? JAMA 2013;307:1585-6
   Web of Science ®Google Scholar
• Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 2007;298:1209-12
   PubMed Web of Science ®Google Scholar
• Ting HH, Brito JP, Montori VM. Shared decision making: science and action. Circ Cardiovasc Qual Outcomes 2014;7:323-7
   PubMed Web of Science ®Google Scholar
• Lin GA, Fagerlin A. Shared decision making: state of the science. Circ Cardiovasc Qual Outcomes 2014;7:328-34
   PubMed Web of Science ®Google Scholar
• Mebius A. Corroborating evidenced medicine. J Eval Clin Pract 2014: published online 16 April 2014, Epub ahead of print. Doi:10.1111/jep.12129
   Google Scholar
• Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA 2013;310:2501-2
   PubMed Web of Science ®Google Scholar
• Andrews JC, Schunemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013;66:726-35
   PubMed Web of Science ®Google Scholar
• Hall KD, Heymsfield SB, Kemnitz JW, et al. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr 2012;95:989-94
   PubMed Web of Science ®Google Scholar
• Wadden TA, Volger S, Tsai AG, et al. Managing obesity in primary care practice: an overview with perspective from the POWER-UP study. Int J Obes (Lond) 2013;37(Suppl 1):S3-11
   PubMedGoogle Scholar
• Moyer VA. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157:373-8
   PubMed Web of Science ®Google Scholar
• Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med 2013;159:3-16
   Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation 2014;129:e28-292
   PubMed Web of Science ®Google Scholar
• Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34:3035-87. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Bays HE, Toth PP, Kris-Etherton PM, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol 2013;7:304-83
   PubMed Web of Science ®Google Scholar
• Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013: published online 7 November 2013, Epub ahead of print. Doi:10.1016/j.jacc.2013.11.003
   Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2013: published online 7 November 2013, Epub ahead of print. Doi:10.1016/j.jacc.2013.11.004
   Google Scholar
• Kones R. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag 2013;9:617-70
   PubMedGoogle Scholar
• Gregg E, Chen H, Wagenknecht L, et al. Impact of intensive lifestyle intervention on the remission of type 2 diabetes: the Look AHEAD Study. JAMA 2012;308:2489-96
   PubMed Web of Science ®Google Scholar
• Brancati F, Evans M, Furberg C, et al. Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) study. Clin Trials 2012;9:113-24
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Weight loss does not lower heart disease risk from type 2 diabetes. Available at: http://www.nih.gov/news/health/oct2012/niddk-19.htm [Last accessed 10 May 2014]
   Google Scholar
• Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145-54
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity (Silver Spring) 2014;1:5-13
   Google Scholar
• Huggins GS, Papandonatos GD, Erar B, et al. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet 2013;6:391-9
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
   PubMed Web of Science ®Google Scholar
• Korda RJ, Liu B, Clements MS, et al. Prospective cohort study of body mass index and the risk of hospitalisation: findings from 246,361 participants in the 45 and Up Study. Int J Obes (Lond) 2013;37:790-9
   PubMed Web of Science ®Google Scholar
• Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014;370:233-44
   PubMed Web of Science ®Google Scholar
• Masters RK, Reither EN, Powers DA, et al. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health 2013;103:1895-901
   PubMed Web of Science ®Google Scholar
• Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012;380:219-29
   PubMed Web of Science ®Google Scholar
• McAuley PA, Artero EG, Sui X, et al. Fitness, fatness, and survival in adults with prediabetes. Diabetes Care 2014;37:529-36
   PubMed Web of Science ®Google Scholar
• Alberti KZP. Diabetes: a look to the future. Lancet Diabetes Endocrinol 2013;13:62154-6
   Google Scholar
• Yates T, Haffner SM, Schulte PJ, et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet 2014;383:1059-66
   Google Scholar
• Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014;383:970-83
   Google Scholar
• Mora S, Wenger NK, Demicco DA, et al. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation 2012;125:1979-87
   PubMed Web of Science ®Google Scholar
• Long GH, Cooper AJM, Wareham NJ, et al. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetes patients: a cohort analysis of the ADDITION-Cambridge study. Diabetes Care 2014: published online 21 March 2014, Epub ahead of print. Doi: 10.2337/dc13-1731
   Google Scholar
• Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-90
   PubMed Web of Science ®Google Scholar
• Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 2013;97:505-16
   PubMed Web of Science ®Google Scholar
• Salas-Salvado J, Bulló M, Estruch R, et al. Prevention of diabetes with Mediterranean diets. A subgroup analysis of a randomized trial. Ann Int Med 2014;160:1-10
   PubMed Web of Science ®Google Scholar
• Hajhosseiny R, Khavandi K, Mashayekhi S, et al. Cardiovascular protection in type 2 diabetes: time to ADVANCE management ACCORDing to the evidence. Res Reports Clinical Cardiol 2014;5:1-9
   Google Scholar
• Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther 2011;5:325-80
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Papageorgiou N, Androulakis E, et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol 2013;62:667-76
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39
   PubMed Web of Science ®Google Scholar
• Sun C, Burgner DP, Ponsonby AL, et al. Effects of early-life environment and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies. Pediatr Res 2013;73:523-30
   PubMed Web of Science ®Google Scholar
• Wang G, Divall S, Radovick S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA 2014;311:587-96
   PubMed Web of Science ®Google Scholar
• Cunningham SA, Kramer MR, Narayan KM. Incidence of childhood obesity in the United States. N Engl J Med 2014;370:403-11
   PubMed Web of Science ®Google Scholar
• Savoye M, Caprio S, Dziura J, et al. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care 2014;37:317-24
   PubMed Web of Science ®Google Scholar
• Giannini C, Weiss R, Cali A, et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 2012;61:606-14
   PubMed Web of Science ®Google Scholar
• Strippoli GF, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008;336:645-51
   PubMed Web of Science ®Google Scholar
• Nikolic D, Banach M, Nikfar S, et al. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 2013;168:5437-47
   PubMed Web of Science ®Google Scholar
• Chadderdon SM, Belcik JT, Bader L, et al. Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance. Circulation 2014;129:471-8
   PubMed Web of Science ®Google Scholar
• Evidence-based medicine, in its place. Lancet 1995;346:785
   Google Scholar
• Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-2
   PubMed Web of Science ®Google Scholar